BlackRock Fund Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$169K Buy
67,239
+1,700
+3% +$4.55K ﹤0.01% 3466
2016
Q3
$204K Sell
65,539
-10,033
-13% -$24.3K ﹤0.01% 3444
2016
Q2
$128K Buy
75,572
+15,701
+26% +$28.5K ﹤0.01% 3595
2016
Q1
$108K Sell
59,871
-4,740
-7% -$9.76K ﹤0.01% 3647
2015
Q4
$218K Buy
64,611
+2,073
+3% +$8.71K ﹤0.01% 3496
2015
Q3
$333K Sell
62,538
-1,656
-3% -$11.3K ﹤0.01% 3303
2015
Q2
$415K Buy
64,194
+41,788
+187% +$250K ﹤0.01% 3260
2015
Q1
$110K Sell
22,406
-1,520
-6% -$7.53K ﹤0.01% 3602
2014
Q4
$120K Buy
23,926
+1,710
+8% +$7.55K ﹤0.01% 3591
2014
Q3
$113K Sell
22,216
-1,615
-7% -$9.35K ﹤0.01% 3617
2014
Q2
$150K Buy
23,831
+680
+3% +$4.79K ﹤0.01% 3565
2014
Q1
$225K Buy
+23,151
New +$179K ﹤0.01% 3434

Other funds holding FATE